top of page

Career

UPCOMING EVENTS

5th October 2023

In Person Annual Meeting @ University of Freiburg, University Medical Centre, Dept. of Radiology, Medical Physics

PAST EVENTS

May 2nd, 2023

QuE-MRT General Assembly (Virtual)

 

October 12th - 13th, 2022

QuE-MRT KICK-OFF Meeting @NVision, Ulm

 

September 1st, 2022

Project start

PARTNERS

Frame 2.png
Frame 2.png
Logo_of_the_Technical_University_of_Munich.svg.png
Frame 2.png
Frame 2.png
Siemens_Healthineers_logo.svg.png
Frame 2.png
Picture5.png
Frame 2.png
Frame 2.png
1200px-Klinikum_rechts_der_Isar_logo.svg.png
Frame 2.png
Frame 2.png
Picture3.png
Picture7.png

Funded by:

YOUR CONTACTS AT NVISION

Ilai Schwartz.jpg

Ilai Schwartz, M.Sc
Project Coordinator

Mor's passport photo.JPG

Mor Schwartz
Operations

Stephan_I_edited_edited.jpg

Dr. Stephan Knecht
Hyperpolarized MRI Research

ChrisAM_II.png

Dr. Christoph A. Müller
MRI Sequences

Shdema.jpg

Shdema Epstein, M.D., M.Sc
Pre-clinical & Clinical Development

Vincent.jpg

Vincent Guyot
Product Development

PUBLIC INFORMATION

SquareGreen.png

MOTIVATION

Cancer is the second leading cause of mortality and morbidity worldwide. Despite new diagnostic tools, cancer remains a major societal challenge due to three factors: late diagnosis, invasive and costly diagnostic methods, and the difficulty and large amount of time required to assess the effectiveness of treatment. A breakthrough technology, "hyperpolarized magnetic resonance imaging", offers the first viable, non-radioactive solution for the non-invasive diagnosis and staging of cancer using a standard magnetic resonance imaging (MRI) scanner.

SquareGreen.png

AIMS & APPROACH

The aim is to provide a clinically and commercially viable end-to-end platform to produce, detect and visualize quantum-enhanced hyperpolarized MRI agents in MRI scanners for animals and for humans. To achieve these goals, QuE-MRT brings together leading industrial, clinical and academic partners in the fields of quantum sensing and medical imaging, with combined expertise in translating quantum applications, bringing them to production readiness and clinical development.

SquareGreen.png

INNOVATION & PROSPECTS

By exploiting a pure quantum state of hydrogen via coherent quantum control over a system of 5 to 7 spins, it has been demonstrated for the first time that quantum technologies can achieve clinically relevant polarization, at room temperature and in a short time, in a cost-effective and user-friendly manner. The consortium plans to validate and demonstrate the immense diagnostic value of the technology for oncology patients through initial clinical trials in high prevalence tumors.

Group photo_QuE-MRT.jpg

*Photo by Jochen Scheuer, NVision

bottom of page